AMP as a Better Delivery System of Adenosine

NCT00179010 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Study was terminated because funding could not be secured

Conditions

Ischemia

Interventions

DRUG: Adenosine
DRUG: Adenosine Mono Phosphate (AMP)

Sponsor

Vanderbilt University Medical Center